Biomaneo

Dijon, France Founded: 2016 • Age: 10 yrs Acquired By Shimadzu Corporation
Neonatal screening kits for sickle cell disease are developed.
Request Access

About Biomaneo

Biomaneo is a company based in Dijon (France) founded in 2016 by Patrick Ducoroy and Valerie GEOFFROY was acquired by Shimadzu Corporation in May 2023.. Biomaneo offers products and services including Chemistry and Diagnostics Products. Biomaneo operates in a competitive market with competitors including Sanguina, DiaSpect, Blaze Medical Devices, Clinical Diagnostic Solutions and Aviv Biomedical, among others.

  • Headquarter Dijon, France
  • Founders Patrick Ducoroy, Valerie GEOFFROY
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Biomaneo

Biomaneo offers a comprehensive portfolio of products and services, including Chemistry and Diagnostics Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Products for chemistry and diagnostics applications in healthcare.

Funding Insights of Biomaneo

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Biomaneo

Biomaneo has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Shimadzu Corporation. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Medical imaging systems, industrial machinery, and analytical instruments are provided.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Biomaneo

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Biomaneo

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Biomaneo Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Biomaneo

Biomaneo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sanguina, DiaSpect, Blaze Medical Devices, Clinical Diagnostic Solutions and Aviv Biomedical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
POC anemia test is conducted using a single blood droplet.
domain founded_year HQ Location
Handheld hemoglobin analyzers for reagent-free whole blood testing are developed.
domain founded_year HQ Location
Testing of blood damage and health of RBC
domain founded_year HQ Location
Offers hematology analyzers, reagents, and services for physician offices and small hospitals.
domain founded_year HQ Location
Aviv Biomedical offers a portfolio of spectrometers and fluorometers.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Biomaneo

Frequently Asked Questions about Biomaneo

When was Biomaneo founded?

Biomaneo was founded in 2016.

Where is Biomaneo located?

Biomaneo is headquartered in Dijon, France. It is registered at Dijon, Bourgogne-franche-comte, France.

Who is the current CEO of Biomaneo?

Patrick Ducoroy is the current CEO of Biomaneo. They have also founded this company.

What does Biomaneo do?

Biomaneo was founded in 2016 in Dijon, France, within the biotechnology sector. Medical test kits for neonatal screening are developed, with the flagship product focusing on sickle cell disease detection through protein analysis of dried blood samples via mass spectrometry. Integration with laboratory information management systems is enabled via the NeoScreening solution for data management, traceability, and analysis. Operations are centered on healthcare diagnostics.

Who are the top competitors of Biomaneo?

Biomaneo's top competitors include Sanguina, DiaSpect and Blaze Medical Devices.

What products or services does Biomaneo offer?

Biomaneo offers Chemistry and Diagnostics Products.

Who are Biomaneo's investors?

Biomaneo has 1 investor. Key investors include Shimadzu Corporation.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available